fashion -WSS

fashion

author：knowledge 2025-10-01 18:35:24 - browse：96258

Bristol Myers Squibb sign — Courtesy Bristol Myers Squibb

Bristol Myers Squibb will pay $4.1 billion for RayzeBio, the companies said Tuesday, buying into the fast-growing field of using targeted doses of radiation to treat cancer.

RayzeBio, which raised about $350 million in a September initial public offering, is working in radiopharmaceuticals, which pair the tumor-killing power of radiation with the precision of targeted cancer therapies. The company is currently running a pivotal trial of its most advanced drug, RYZ101, in neuroendocrine cancer and has a pipeline of treatments for kidney, liver, and other cancers.

Bristol Myers will pay $62.50 in cash per share of RayzeBio, a roughly 115% premium to the company’s recent trading and more than triple the company’s IPO price.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： CRISPR pioneers react to Casgevy, first gene

explore

WSS

Ransomware attacks on hospitals: Study outlines patient impact

U.K. considers world's first use of meningitis vaccine to address gonorrhea

Surge of respiratory disease in China has likely explanation

CMS should re

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

CRISPR pioneers react to Casgevy, first gene

Wikipedia

fashion

focus

Hollywood unions extend contract negotiations for actors

Morphosys mixed study results for blood cancer drug

Jerome Adams on the need for new antivirals for Covid

After sickle

Moonlake's readout produced a cash windfall. Risks remain

Spinal cord stimulation reduces pain in amputees, study finds

Supreme Court strikes down use of affirmative action

U.K. considers world's first use of meningitis vaccine to address gonorrhea

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

knowledge

Chemotherapy shortages won’t get better under Biden’s latest plan

Teach medical students about patients with intellectual disabilities

Pregnancy discrimination could be enabled by AI

NYU radiologists take on the challenge of expensive MRI machines

Why medical students are struggling with mental health

What causes an itch? Researchers may have solved the mystery

knowledge

explore

hotspot

focus